BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Annese V, Rogai F, Settesoldi A, Bagnoli S. PPARγ in Inflammatory Bowel Disease. PPAR Res 2012;2012:620839. [PMID: 22997506 DOI: 10.1155/2012/620839] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fernandez-Boyanapalli RF, Falcone EL, Zerbe CS, Marciano BE, Frasch SC, Henson PM, Holland SM, Bratton DL. Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment. J Allergy Clin Immunol 2015;136:1399-1401.e3. [PMID: 26386811 DOI: 10.1016/j.jaci.2015.07.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
2 Tesena P, Yingchutrakul Y, Roytrakul S, Taylor J, Angkanaporn K, Wongtawan T. Searching for serum protein markers of equine squamous gastric disease using gel electrophoresis and mass spectrometry. Equine Vet J 2019;51:581-6. [PMID: 30636330 DOI: 10.1111/evj.13068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tuna H, Avdiushko RG, Sindhava VJ, Wedlund L, Kaetzel CS, Kaplan AM, Bondada S, Cohen DA. Regulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment. J Leukoc Biol 2014;95:471-85. [PMID: 24295831 DOI: 10.1189/jlb.0713408] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
4 Fuhr L, Rousseau M, Plauth A, Schroeder FC, Sauer S. Amorfrutins Are Natural PPARγ Agonists with Potent Anti-inflammatory Properties. J Nat Prod 2015;78:1160-4. [DOI: 10.1021/np500747y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
5 Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, de la Lastra CA. Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J Nutr Biochem. 2013;24:1401-1413. [PMID: 23337347 DOI: 10.1016/j.jnutbio.2012.11.008] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 9.3] [Reference Citation Analysis]
6 Su Y, Shen X, Chen J, Isales CM, Zhao J, Shi XM. Differentially expressed genes in PPARγ-deficient MSCs. Mol Cell Endocrinol 2018;471:97-104. [PMID: 28774780 DOI: 10.1016/j.mce.2017.07.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Manickam R, Duszka K, Wahli W. PPARs and Microbiota in Skeletal Muscle Health and Wasting. Int J Mol Sci 2020;21:E8056. [PMID: 33137899 DOI: 10.3390/ijms21218056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chen Y, Yang B, Ross RP, Jin Y, Stanton C, Zhao J, Zhang H, Chen W. Orally Administered CLA Ameliorates DSS-Induced Colitis in Mice via Intestinal Barrier Improvement, Oxidative Stress Reduction, and Inflammatory Cytokine and Gut Microbiota Modulation. J Agric Food Chem 2019;67:13282-98. [DOI: 10.1021/acs.jafc.9b05744] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
9 Ran SW, Mu CL, Zhu WY. Mechanisms for butyrate to inhibit ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2018; 26(14): 856-861 [DOI: 10.11569/wcjd.v26.i14.856] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Nepelska M, de Wouters T, Jacouton E, Béguet-Crespel F, Lapaque N, Doré J, Arulampalam V, Blottière HM. Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells. Sci Rep 2017;7:43199. [PMID: 28266623 DOI: 10.1038/srep43199] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
11 Nyambe MN, Koekemoer TC, van de Venter M, Goosen ED, Beukes DR. In Vitro Evaluation of the Phytopharmacological Potential of Sargassum incisifolium for the Treatment of Inflammatory Bowel Diseases. Medicines (Basel) 2019;6:E49. [PMID: 30959861 DOI: 10.3390/medicines6020049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Venkataraman B, Almarzooqi S, Raj V, Dudeja PK, Bhongade BA, Patil RB, Ojha SK, Attoub S, Adrian TE, Subramanya SB, Mandard S. α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study. PPAR Research 2022;2022:1-22. [DOI: 10.1155/2022/5498115] [Reference Citation Analysis]
13 Mohamed ME, Elsayed SA, Madkor HR, Eldien HMS, Mohafez OM. Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways. Intest Res 2021;19:194-205. [PMID: 32819032 DOI: 10.5217/ir.2020.00021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Tiefenbach J, Magomedova L, Liu J, Reunov AA, Tsai R, Eappen NS, Jockusch RA, Nislow C, Cummins CL, Krause HM. Idebenone and coenzyme Q10 are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases. Dis Model Mech 2018;11:dmm034801. [PMID: 30171034 DOI: 10.1242/dmm.034801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
15 Lima Ede A, Lima MM, Marques CD, Duarte AL, Pita Ida R, Pita MG. Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis. An Bras Dermatol 2013;88:1029-35. [PMID: 24474126 DOI: 10.1590/abd1806-4841.20132653] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
16 Gao JW, Zeng L, Zhang AQ, Wang X, Pan W, Du DY, Zhang LY, Gu W, Jiang JX. Identification of Haplotype Tag Single-Nucleotide Polymorphisms within the PPAR Family Genes and Their Clinical Relevance in Patients with Major Trauma. Int J Environ Res Public Health 2016;13:374. [PMID: 27023591 DOI: 10.3390/ijerph13040374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Takahashi Y, Sato S, Kurashima Y, Lai CY, Otsu M, Hayashi M, Yamaguchi T, Kiyono H. Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells. EBioMedicine. 2017;23:34-45. [PMID: 28789943 DOI: 10.1016/j.ebiom.2017.07.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
18 Arafa EA, Mohamed WR, Zaher DM, Omar HA. Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways. Toxicol Appl Pharmacol 2020;391:114919. [PMID: 32045587 DOI: 10.1016/j.taap.2020.114919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Liu Y, Wan W, Fang F, Guo L, Zhao Y, Zhang X, Huang F. Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis. J Clin Lab Anal 2018;32:e22340. [PMID: 29055064 DOI: 10.1002/jcla.22340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Fernandes P, MacSharry J, Darby T, Fanning A, Shanahan F, Houston A, Brint E. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma? Clin Exp Immunol. 2016;183:358-368. [PMID: 26462859 DOI: 10.1111/cei.12732] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
21 Yamamoto-furusho JK, Fonseca-camarillo G. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:2683-95. [DOI: 10.1097/mib.0000000000000500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
22 Bersuder E, Terciolo C, Lechevrel M, Martin E, Quesnelle C, Freund JN, Reimund JM, Gross I. Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. Biomed Pharmacother 2021;146:112543. [PMID: 34929577 DOI: 10.1016/j.biopha.2021.112543] [Reference Citation Analysis]
23 Li MY, Zhang ZH, Wang Z, Zuo HX, Wang JY, Xing Y, Jin CH, Xu GH, Piao LX, Ma J, Jin X. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγ. Pharmacological Research 2019;147:104355. [DOI: 10.1016/j.phrs.2019.104355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
24 Katkar GD, Sayed IM, Anandachar MS, Castillo V, Vidales E, Toobian D, Usmani F, Sawires JR, Leriche G, Yang J, Sandborn WJ, Das S, Sahoo D, Ghosh P. Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease. Commun Biol 2022;5:231. [PMID: 35288651 DOI: 10.1038/s42003-022-03168-4] [Reference Citation Analysis]
25 Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019;8:E628. [PMID: 31234447 DOI: 10.3390/cells8060628] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
26 Serra D, Almeida LM, Dinis TCP. The Impact of Chronic Intestinal Inflammation on Brain Disorders: the Microbiota-Gut-Brain Axis. Mol Neurobiol 2019;56:6941-51. [DOI: 10.1007/s12035-019-1572-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
27 Verbeke KA, Boesmans L, Boets E. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation? Proc Nutr Soc. 2014;73:490-497. [PMID: 24969143 DOI: 10.1017/s0029665114000639] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
28 Serra D, Almeida LM, Dinis TC. Anti-inflammatory protection afforded by cyanidin-3-glucoside and resveratrol in human intestinal cells via Nrf2 and PPAR-γ: Comparison with 5-aminosalicylic acid. Chem Biol Interact 2016;260:102-9. [PMID: 27818126 DOI: 10.1016/j.cbi.2016.11.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
29 Hyder A. PGlyRP3 concerts with PPARγ to attenuate DSS-induced colitis in mice. Int Immunopharmacol 2019;67:46-53. [PMID: 30530168 DOI: 10.1016/j.intimp.2018.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
30 Statovci D, Aguilera M, MacSharry J, Melgar S. The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. Front Immunol. 2017;8:838. [PMID: 28804483 DOI: 10.3389/fimmu.2017.00838] [Cited by in Crossref: 163] [Cited by in F6Publishing: 130] [Article Influence: 32.6] [Reference Citation Analysis]
31 Rahimian R, Zirak MR, Keshavarz M, Fakhraei N, Mohammadi-farani A, Hamdi H, Mousavizadeh K. Involvement of PPAR γ in the protective action of tropisetron in an experimental model of ulcerative colitis. Immunopharmacology and Immunotoxicology 2016;38:432-40. [DOI: 10.1080/08923973.2016.1231202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
32 Roudsari NM, Lashgari NA, Zandi N, Pazoki B, Momtaz S, Sahebkar A, Abdolghaffari AH. PPARγ: A turning point for irritable bowel syndrome treatment. Life Sci 2020;257:118103. [PMID: 32681913 DOI: 10.1016/j.lfs.2020.118103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Malmuthuge N, Liang G, Guan LL. Regulation of rumen development in neonatal ruminants through microbial metagenomes and host transcriptomes. Genome Biol 2019;20:172. [PMID: 31443695 DOI: 10.1186/s13059-019-1786-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
34 Im SA, Kim JW, Kim HS, Park CS, Shin E, Do SG, Park YI, Lee CK. Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel. Int Immunopharmacol 2016;40:428-35. [PMID: 27697726 DOI: 10.1016/j.intimp.2016.09.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
35 Sim S, Hibberd ML. Caenorhabditis elegans susceptibility to gut Enterococcus faecalis infection is associated with fat metabolism and epithelial junction integrity. BMC Microbiol 2016;16:6. [PMID: 26769134 DOI: 10.1186/s12866-016-0624-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
36 Shen P, Zhang Z, He Y, Gu C, Zhu K, Li S, Li Y, Lu X, Liu J, Zhang N, Cao Y. Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage. Life Sci. 2018;196:69-76. [PMID: 29355546 DOI: 10.1016/j.lfs.2018.01.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
37 Oh HYP, Visvalingam V, Wahli W. The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology. FASEB J 2019;33:9706-30. [PMID: 31237779 DOI: 10.1096/fj.201802681RR] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
38 Yang J, Qian K, Wang C, Wu Y. Roles of Probiotic Lactobacilli Inclusion in Helping Piglets Establish Healthy Intestinal Inter-environment for Pathogen Defense. Probiotics Antimicrob Proteins 2018;10:243-50. [PMID: 28361445 DOI: 10.1007/s12602-017-9273-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
39 Yamamoto-Furusho JK, Jacintez-Cazares M, Furuzawa-Carballeda J, Fonseca-Camarillo G. Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis. Dis Markers 2014;2014:932530. [PMID: 25548431 DOI: 10.1155/2014/932530] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
40 de Mesquita FC, Bitencourt S, Caberlon E, da Silva GV, Basso BS, Schmid J, Ferreira GA, de Oliveira FDS, de Oliveira JR. Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell. European Journal of Pharmacology 2013;720:320-5. [DOI: 10.1016/j.ejphar.2013.09.067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
41 Fu Y, Ma J, Shi X, Song X, Yang Y, Xiao S, Li J, Gu W, Huang Z, Zhang J, Chen J. A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway. Biochemical Pharmacology 2017;135:126-38. [DOI: 10.1016/j.bcp.2017.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]